Involvement of the L-DOPA receptor GPR143 in acute and chronic actions of methylphenidate

Methylphenidate (MPH) and methamphetamine (METH) are the current treatments of choice for attention deficit/hyperactivity disorder. We previously reported that METH induces the release of dopamine (DA) and of the neurotransmitter candidate L-3,4-dihydroxyphenylalanine (L-DOPA). In contrast, we here...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hiraku Uchimura, Kaori Kanai, Masami Arai, Miyu Inoue, Akitoyo Hishimoto, Daiki Masukawa, Yoshio Goshima
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-07-01
Col·lecció:	Journal of Pharmacological Sciences
Matèries:	L-DOPA GPR143 Methylphenidate
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S1347861323000282
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!